Recent VRTX News
- Vertex to Announce First Quarter 2026 Financial Results on May 4th • Business Wire • 04/06/2026 08:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/03/2026 08:53:51 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/02/2026 08:06:12 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/02/2026 08:04:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/02/2026 08:02:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 04/01/2026 05:02:16 PM
- Vertex Announces US FDA Approval for Label Extensions of ALYFTREK® and TRIKAFTA®, Expanding Availability of These Medicines to ~95% of All People With CF in the United States • Business Wire • 04/01/2026 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 08:10:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/31/2026 08:03:47 PM
- Anti-Aging Protein Research Takes a Step Forward with Cell Cloning • PR Newswire (Canada) • 03/24/2026 03:05:00 PM
- Anti-Aging Protein Research Takes a Step Forward with Cell Cloning • PR Newswire (US) • 03/24/2026 03:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/17/2026 08:04:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/13/2026 08:11:50 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/13/2026 03:38:02 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2026 01:44:31 PM
- Vertex Shares Jump After Positive Phase 3 Kidney Drug Results • IH Market News • 03/10/2026 03:45:15 PM
- Vertex Announces Positive Week 36 Interim Analysis Results for Primary and All Secondary Endpoints in the RAINIER Phase 3 Trial of Povetacicept in Adults With IgA Nephropathy • Business Wire • 03/09/2026 08:02:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2026 09:05:56 PM
- Vertex to Participate in Upcoming March Investor Conferences • Business Wire • 03/05/2026 09:00:00 PM
- Vertex to Present New Data on JOURNAVX® That Demonstrates Effective Pain Management Following Aesthetic and Reconstructive Procedures • Business Wire • 03/05/2026 03:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/04/2026 09:21:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/04/2026 03:09:56 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 09:41:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 09:34:23 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 09:25:20 PM
